(Access to Coverage of Tobacco Treatment In Our Nation)
Shaping Policies | Improving Health
May 31, 2012 The same gene variations that make it difficult to stop smoking also increase the likelihood that heavy smokers will respond to nicotine-replacement therapy and drugs that thwart cravings, a new study shows. The study suggests it may one day be possible to predict which patients are most likely to benefit from drug treatments for nicotine addiction. The researchers, Beirut and Chen, analyzed data from more than 5,000 smokers who participated in community-based studies and more than 1,000 smokers in a clinical treatment study. The scientists focused on the relationship between the participant’s ability to quit smoking successfully and genetic variations that have been associated with risk for heavy smoking and nicotine dependence.
For More Information:
Complete the form below to subscribe to the ActionToQuit listserv. Join the conversation about tobacco control policy and receive weekly updates.
All Content © ActionToQuit. All Rights Reserved